Summarized by Masters of Longevity from Longevity Technology.
Novartis terminated its specific collaboration with BioArctic’s BrainTransporter program.
Key Takeaways
- BrainTransporter is using the transferrin receptor to boost brain uptake.
- Novartis ended its specific collaboration while other partners remain engaged.
- BrainTransporter is in preclinical development and human proof is pending.
